Citius Oncology Inc.

:CTOR   4:00:00 PM EDT
1.03
-0.10 (-8.85%)
7:53:57 PM EDT: $1.02 -0.01 (-0.97%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)87.34M
Current PEN/A
Forward PE N/A
2yr Forward PE 1.54
See more stats
Estimates Current Quarter
Revenue$4.37 Million
Adjusted EPS-$0.04
See more estimates
10-Day MA$1.13
50-Day MA$1.36
200-Day MA$1.54
See more pivots

Citius Oncology Inc. Stock, :CTOR

11 Commerce Drive, 1st floor, Cranford, New Jersey 07016
United States of America
Phone:
Number of Employees:

Description

Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.